The effect of cytotoxic drugs on graft-versus-host disease in mice.
D000818:Animals; D000906:Antibodies / Q000032:analysis; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006086:Graft vs Host Disease / Q000188:drug therapy* / Q000276:immunology / Q000401:mortality; D006854:Hydrocortisone / Q000008:administration & dosage / Q000627:therapeutic use*; D007136:Immunoglobulins / Q000032:analysis; D007274:Injections, Intraperitoneal; D008466:Mechlorethamine / Q000008:administration & dosage / Q000627:therapeutic use*; D015122:Mercaptopurine / Q000008:administration & dosage / Q000627:therapeutic use*; D008727:Methotrexate / Q000008:administration & dosage / Q000627:therapeutic use*; D051379:Mice; D016038:Skin Transplantation; D013997:Time Factors; D014181:Transplantation Immunology; D014184:Transplantation, Homologous
D000906:Antibodies; D007136:Immunoglobulins; D008466:Mechlorethamine; D003520:Cyclophosphamide; D015122:Mercaptopurine; D006854:Hydrocortisone; D008727:Methotrexate